girisopam has been researched along with tofisopam in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bihel, FJ; Bourguignon, JJ; Hellal, M; Ibrahim, MA; Justiniano, H; Lugnier, C; Schmitt, M | 1 |
Arányi, P; Fekete, MI; Horváth, EJ; Salamon, C | 1 |
Bakonyi, A; Fekete, MI; Horváth, EJ; Palkovits, M; Salamon, C | 1 |
3 other study(ies) available for girisopam and tofisopam
Article | Year |
---|---|
New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam.
Topics: Benzodiazepines; Inhibitory Concentration 50; Papaverine; Phosphodiesterase 4 Inhibitors | 2011 |
A novel specific binding site for anxiolytic homophthalazines in the rat brain.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Binding Sites; Brain; Cations, Divalent; Magnesium; Male; Radioligand Assay; Rats | 1992 |
[(3)H]-girisopam, a novel selective benzodiazepine for the 2, 3-benzodiazepine binding site.
Topics: Adult; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Binding Sites; Binding, Competitive; Corpus Striatum; Diazepam; Dopamine; Flunitrazepam; gamma-Aminobutyric Acid; Glutamine; Humans; Male; Organ Specificity; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Serotonin; Structure-Activity Relationship | 1999 |